Tear Osmolarity

The
TearLab Osmolarity test is used to test the homeostatic
osmo-regulation of the tears, and is a key biomarker to identify both
aqueous deficiency and its relation to Dry Eye Disease by collecting
a small sample of tears and analyzing the tear osmolarity.
InflammaDry

InflammaDry
is a rapid, immunoassay test for the visual, qualitative, in vitro
detection of elevated levels of the MMP-9 protein in human tears,
from patients suspected of having dry eye. MMP-9 is a nonspecific
inflammatory marker that has consistently been shown to be elevated
in the tears of patients with dry eyes. InflammaDry is to be used to
aid in the diagnosis of dry eye, in conjunction with other methods of
clinical evaluation.

TearCare

TearCare
is an alternative for dry eye patients who have dryness as a result
of Meibomian Gland Disorder (MGD). MGD is blockage or some form of
dysfunction of the meibomian glands. The Meibomian glands are located
along the rims of the eyelid and they produce meibum, an oily
substance that prevents evaporation of the eye’s tear film.
TearCare works by applying localized heat to the eyelids; this heat
functions to loosen up the blocked glands and allow the doctor to
express them.
LipiScan

LipiScan
Dynamic Meibomian Imager (DMI) is an ophthalmic imaging device
intended for use by a physician or trained optometric technician in
adult patients to capture, archive, manipulate, and store digital
images of the Meibomian glands. The
Meibomian glands are located along the rims of the eyelid and they
produce meibum, an oily substance that prevents evaporation of the
eye’s tear film. These images
allow the physician to identify any truncation, elimination, and/or
blockage of these glands, which may be the cause of dry eyes.